Maura Harrigan
Overview
Explore the profile of Maura Harrigan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
705
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoobler R, Puklin L, Harrigan M, Cartmel B, Li F, Sanft T, et al.
J Cancer Surviv
. 2024 Nov;
PMID: 39528779
Purpose: To investigate participant characteristics associated with clinically meaningful weight loss (≥ 5% weight loss) among breast cancer survivors participating in the Lifestyle, Exercise, and Nutrition (LEAN) study. Methods: Female...
2.
Puklin L, Irwin M, Sanft T, Ferrucci L, Harrigan M, McGowan C, et al.
Support Care Cancer
. 2024 Aug;
32(9):590.
PMID: 39141176
Purpose: Use qualitative and quantitative methods to explore factors influencing the adoption of guideline-based physical activity (PA) and dietary recommendations among participants enrolled in a lifestyle intervention during and after...
3.
Puklin L, Ferrucci L, Harrigan M, McGowan C, Zupa M, Cartmel B, et al.
Cancer
. 2024 Mar;
130(14):2440-2452.
PMID: 38470431
Background: Little is known about improving physical activity (PA) and diet during and after chemotherapy for breast cancer. This secondary analysis examines changes in PA and diet quality during a...
4.
Puklin L, Harrigan M, Cartmel B, Sanft T, Gottlieb L, Zhou B, et al.
Cancers (Basel)
. 2023 Oct;
15(19).
PMID: 37835412
Lifestyle interventions for breast cancer survivors have proved effective at stimulating positive behavior change and promoting healthy weight loss, although integrating these programs into clinical practice is challenging. We evaluated...
5.
Sanft T, Harrigan M, McGowan C, Cartmel B, Zupa M, Li F, et al.
J Clin Oncol
. 2023 Sep;
41(34):5285-5295.
PMID: 37656930
Purpose: Successful completion of chemotherapy is critical to improve breast cancer outcomes. Relative dose intensity (RDI), defined as the ratio of chemotherapy delivered to prescribed, is a measure of chemotherapy...
6.
Cao A, Cartmel B, Li F, Gottlieb L, Harrigan M, Ligibel J, et al.
JAMA Netw Open
. 2023 Aug;
6(8):e2326463.
PMID: 37526937
Importance: Chemotherapy-induced peripheral neuropathy (CIPN), one of the most common and severe adverse effects of chemotherapy, is associated with worse quality of life among survivors of ovarian cancer. Currently, there...
7.
Cartmel B, Li F, Zhou Y, Gottlieb L, Lu L, Mszar R, et al.
Cancer Med
. 2023 Jun;
12(14):15492-15503.
PMID: 37269192
Background: In randomized trials in women with breast cancer, exercise has been shown to have beneficial effects on cancer-related circulating biomarkers that may impact survival. Such studies are lacking for...
8.
Pichardo M, Sanft T, Ferrucci L, Romero-Ramos Y, Cartmel B, Harrigan M, et al.
Front Oncol
. 2023 Mar;
13:1079293.
PMID: 36994212
Background: A growing number of lifestyle interventions are being developed to promote weight loss and adoption of a healthful lifestyles among breast cancer survivors; yet Black and Latina women remain...
9.
Cao A, Cartmel B, Li F, Gottlieb L, Harrigan M, Ligibel J, et al.
J Cancer Surviv
. 2022 Dec;
17(2):535-543.
PMID: 36550261
Purpose: Factors associated with improving exercise in ovarian cancer survivors remain unknown. We explored characteristics associated with exercise adherence among women treated for ovarian cancer in the Women's Activity and...
10.
Pariser A, Brita J, Harrigan M, Capozza S, Khairallah A, Sanft T
J Cancer Educ
. 2022 Apr;
38(2):625-631.
PMID: 35394562
Our pilot study aimed to evaluate the needs of community oncology providers with regard to cancer survivorship education, develop a survivorship curriculum based on the needs assessment, and evaluate the...